An augmented immune response explains the adverse course of COVID-19 in patients with hypertension

(BIH at Charit é) COVID-19 patients who also suffer from high blood pressure are more likely to fall severely ill with the disease, which also leaves them at greater risk of death. Scientists from the Berlin Institute of Health (BIH) and Charit é - Universit ä tsmedizin Berlin, in collaboration with partners in Heidelberg and Leipzig, have now found that the immune cells of patients with hypertension are already pre-activated, and that this pre-activation is greatly enhanced under COVID-19.
Source: EurekAlert! - Biology - Category: Biology Source Type: news